Research advances in biotechnology such as 3D cell culturing, human induced pluripotent stem cells, and gene editing are beginning to emerge as alternatives in predicting the effects of a drug on the human body (PK/PD studies) and could eventually replace some of the animal testing. This is an encouraging sign towards the faster growth especially in moving new disease treatments into the clinic and hence eventually to the patients.
Esco Healthcare products bridges the gap between in vitro and in vivo drug testing that opens up the possibility of a decline in the use of animal models.
